Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★

Published:2011-01-10 Issue:2 Volume:11 Page:336-347
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Reshef R.,Vardhanabhuti S.,Luskin M. R.,Heitjan D. F.,Hadjiliadis D.,Goral S.,Krok K. L.,Goldberg L. R.,Porter D. L.,Stadtmauer E. A.,Tsai D. E.

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2010.03387.x/fullpdf

Reference49 articles.

1. The management of posttransplant lymphoproliferative disorder;Frey;Med Oncol,2007

2. Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: Disappearance after rituximab therapy does not predict clinical response;Yang;Blood,2000

3. Persistence of the Epstein-Barr virus and the origins of associated lymphomas [see comment];Thorley-Lawson;N Engl J Med,2004

4. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy;Starzl;Lancet,1984

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiologic evaluation of the kidney transplant donor and recipient;Abdominal Radiology;2024-07-10

2. Onkologische Herausforderungen bei Patienten mit chronischem Nierenversagen an der Dialyse und nach Transplantation;Die Nephrologie;2024-07-01

3. Treatment of Epstein-Barr Virus infection in immunocompromised patients;Biochemical Pharmacology;2024-07

4. A disease warranting attention from neurosurgeons: primary central nervous system post-transplant lymphoproliferative disorder;Frontiers in Neurology;2024-05-15

5. Post-transplant lymphoproliferative disorders following kidney transplantation: A literature review with updates on risk factors, prognostic indices, screening strategies, treatment and analysis of donor type;Transplantation Reviews;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3